Augusto H Podesta, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 30 Shelburne Rd, Stamford, CT 06902 Phone: 203-276-7424 |
Robert C Babkowski, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Shelburne Rd, Stamford, CT 06902 Phone: 860-673-9984 |
Kyung Park, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 272 Main St, 2f, Stamford, CT 06901 Phone: 213-718-6814 |
Dr. Donald Lowell Price Jr., M.D. Pathology - Neuropathology Medicare: Accepting Medicare Assignments Practice Location: 29 Hospital Plz Ste 602, Stamford, CT 06902 Phone: 203-276-4464 Fax: 203-276-4468 |
Bo Xu, M.D. Pathology - Anatomic Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Shelburne Rd, Stamford, CT 06902 Phone: 203-276-4067 Fax: 203-276-7063 |
Raymond A Baer, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Shelburne Rd, Stamford Hospital, Dept Of Pathology, Stamford, CT 06902 Phone: 203-276-7420 Fax: 203-276-7122 |
News Archive
Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical Imaging (PMI) with the 2015 European Frost & Sullivan Award for Technology Leadership.
New research at the University of Bath suggests that using emollient creams to relieve the symptoms of eczema could actually make the condition worse.
Research shows that inhibiting necroptosis, a form of cell death, could be a novel therapeutic approach for treating chronic obstructive pulmonary disease, an inflammatory lung condition, also known as emphysema, that makes it difficult to breathe.
People who lack essential antioxidants, and who have high levels of sunlight exposure, have a higher risk of developing advanced macular degeneration (AMD), according to a study published today in the journal Archives of Ophthalmology. AMD is the leading cause of poor vision in the UK.
GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.
› Verified 3 days ago